The United States will distribute 60 million doses of the vaccine from the British-Swedish company AstraZeneca to other countries. Andy Slavitt, chief White House adviser on coronavirus control, wrote this in his Twitter account.
According to him, the vaccines will be transferred as they become available. Slavitt did not specify where or when the shipments would be sent.
It is noted that the Food and Drug Administration (FDA) has not yet issued approval for the AstraZeneca vaccine in the United States. At the same time, three other drugs have been approved in the country.
White House Coronavirus Response Coordinator Jeff Zients said the U.S. will not experience a need for the AstraZeneca vaccine in the next few months, the Associated Press reported. He said 10 million doses are ready and due for final testing, and another 50 million doses could be ready for shipment in May or June.
Earlier, the European Commission sued vaccine maker AstraZeneca over the disruption of the delivery schedule. The European Commission said the Anglo-Swedish company failed to comply with some provisions of a bilateral contract, after which the body sued on behalf of the 27 EU member states. “What matters to us in this case: the prompt delivery of a sufficient number of doses that were promised to European citizens on the basis of the agreement,” the agency explained.